Structural determinants of procryptdin recognition and cleavage by matrix metalloproteinase-7

被引:73
|
作者
Shirafuji, Y
Tanabe, H
Satchell, DP
Henschen-Edman, A
Wilson, CL
Ouellette, AJ [1 ]
机构
[1] Washington Univ, Sch Med, Dept Pediat, Div Allergy & Pulm Med, St Louis, MO 63110 USA
[2] Univ Calif Irvine, Coll Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA
[3] Univ Calif Irvine, Coll Med, Dept Mol Biol & Biochem, Irvine, CA 92697 USA
[4] Univ Calif Irvine, Coll Med, Dept Pathol, Irvine, CA 92697 USA
关键词
D O I
10.1074/jbc.M210600200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The bactericidal activity of mouse Paneth cell alpha-defensins, or cryptdins, is dependent on processing of cryptdin precursors (pro-Crps) by matrix metallo-proteinase-7 (MMP-7) (Wilson, C. L., Ouellette, A. J., Satchell, D. P., Ayabe, T., Lopez-Boado, Y. S., Stratman, J. L., Hultgren, S. J., Matrisian, L. M., and Parks, W. C. (1999) Science 286, 113-117). To investigate the mechanisms of pro-Crp processing by this enzyme, recombinant pro-Crp4, a His-tagged chimeric pro-Crp (pro-CC), and site-directed mutant precursors of each were digested with MMP-7, and the cleavage products were analyzed by NH2-terminal peptide sequencing. Proteolysis of pro-Crp4 with MMP-7 activated in vitro bactericidal activity to the level of the mature Crp4 peptide by cleaving pro-Crp4 at Ser43 down arrow Ile(44) and Ala(53) down arrow Leu(54) in the proregion and near the Crp4 peptide NH2 terminus between Ser(58) down arrow Leu(59). Because the Crp4 NH2 terminus occurs at Gly(61), not Leu(59), AMP-7 is necessary but insufficient to complete the processing of Crp4. Crp activating proteolysis at S58 down arrow L59 was unaffected by 144S/144D or L54S/L54D loss-of-function mutations in pro-Crp4, and a (L59S)-pro-CC mutant was cleaved normally at Ser(43) down arrow Val(44) and Ser(53) down arrow Leu(54) sites but not at the peptide NH2 terminus. C57BL/6 mice contain an abundant (L59S)-Crp4 mutant peptide with Leu(54) at its NH2 terminus resulting from Ala(53) down arrow Leu(54) cleavage and loss-of-function at the Ser(58) down arrow Ser(59) cleavage site. Thus, a-defensins resulting from mutations at AMP-7 cleavage sites exist in mouse populations. A pro-CC substrate containing both L54S and L59S mutations resisted cleavage at Ser(43) down arrow Val(44) completely, showing that cleavage at one or both downstream sites must precede proteolysis at Ser(43) down arrow Val(44). These findings show that NHdP-7 activation of pro-Crps can occur without proteolysis of the proregion, and prosegment fragmentation depends, at least in part, on the release of the Crp peptide from the precursor.
引用
收藏
页码:7910 / 7919
页数:10
相关论文
共 50 条
  • [21] Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma
    Miwa, S
    Miyagawa, S
    Soeda, J
    Kawasaki, S
    CANCER, 2002, 94 (02) : 428 - 434
  • [22] Diagnostic Accuracy of Serum Matrix Metalloproteinase-7 for Biliary Atresia
    Yang, Li
    Zhou, Ying
    Xu, Pei-Pei
    Mourya, Reena
    Lei, Hai-Yan
    Cao, Guo-Qing
    Xiong, Xiao-Li
    Xu, Hui
    Duan, Xu-Fei
    Wang, Na
    Fei, Lin
    Chang, Xiao-Pan
    Zhang, Xi
    Jiang, Meng
    Bezerra, Jorge A.
    Tang, Shao-Tao
    HEPATOLOGY, 2018, 68 : 118A - 118A
  • [23] The impact of stromal matrix metalloproteinase-7 on osteotytic bone metastases
    Lynch, Conor C.
    Matrisian, Lynn M.
    CLINICAL & EXPERIMENTAL METASTASIS, 2007, 24 (04) : 280 - 281
  • [24] Matrix metalloproteinase-7 in periodontitis with type 2 diabetes mellitus
    Zeidan-Chulia, F.
    Yilmaz, D.
    Hakkinen, L.
    Kononen, E.
    Neves de Oliveira, B. -H.
    Guncu, G.
    Uitto, V. -J.
    Caglayan, F.
    Gursoy, U. K.
    JOURNAL OF PERIODONTAL RESEARCH, 2018, 53 (05) : 916 - 923
  • [25] Role of matrix metalloproteinase-7 in the modulation of a Chlamydia trachomatis infection
    Pal, S
    Schmidt, AP
    Peterson, EM
    Wilson, CL
    de la Maza, LM
    IMMUNOLOGY, 2006, 117 (02) : 213 - 219
  • [26] Expression and Prognostic Value of Matrix Metalloproteinase-7 in Colorectal Cancer
    Yang, Bo
    Su, Ke
    Gao, Jianfei
    Rao, Zhiguo
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (03) : 1049 - 1052
  • [27] Contribution of Matrix Metalloproteinase-7 Genotypes to Endometriosis Risk in Taiwan
    Chien, Hung-Ju
    Wang, Yun-Chi
    Chang, Wen-Shin
    Hsieh, Yi-Hsien
    Liu, Yen-Fang
    Yang, Ya-Chen
    Chen, Jaw-Chyun
    Bau, Da-Tian
    Tsai, Chia-Wen
    ANTICANCER RESEARCH, 2024, 44 (07) : 3051 - 3058
  • [28] Diagnostic Accuracy of Serum Matrix Metalloproteinase-7 for Biliary Atresia
    Yang, Li
    Zhou, Ying
    Xu, Pei-pei
    Mourya, Reena
    Lei, Hai-yan
    Cao, Guo-qing
    Xiong, Xiao-li
    Xu, Hui
    Duan, Xu-fei
    Wang, Na
    Fei, Lin
    Chang, Xiao-pan
    Zhang, Xi
    Jiang, Meng
    Bezerra, Jorge A.
    Tang, Shao-tao
    HEPATOLOGY, 2018, 68 (06) : 2069 - 2077
  • [29] Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma
    Yamashita, K
    Mori, M
    Shiraishi, T
    Shibuta, K
    Sugimachi, K
    CLINICAL CANCER RESEARCH, 2000, 6 (03) : 1169 - 1174
  • [30] Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer
    Liao, Cheng-Hsi
    Chang, Wen-Shin
    Tsai, Chia-Wen
    Hu, Pei-Shin
    Wu, Hsi-Chin
    Hsu, Shih-Wei
    Chen, Guan-Liang
    Yueh, Te-Cheng
    Shen, Te-Chun
    Hsia, Te-Chun
    Bau, Da-Tian
    IN VIVO, 2018, 32 (05): : 1045 - 1050